Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02183844 · ClinicalTrials.gov registry record · NA

A System for Preference Assessment in Mental Health

A NA study of Obesity and Schizophrenia, sponsored by University of California, Los Angeles.

Completed
Registry status
NA
Development phase
61
Enrollment target
1
Study location

NCT02183844: Completed NA study of Obesity and Schizophrenia, sponsored by University of California, Los Angeles.

NCT02183844 is a NA study of Obesity and Schizophrenia that has completed, run by University of California, Los Angeles. The registered enrollment target is 61 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02183844, a NA study of Obesity and Schizophrenia, has completed, sponsored by University of California, Los Angeles.

COMPLETED
Registry status
NA
Development phase
61 participants
Enrollment target
1
Study location

Study Summary

It is important that individuals with serious mental illness make informed choices among alternative healthcare treatments based on their preferences. However, at present, individuals' preferences are often not being elicited, nor used to guide which treatments are made available. In this pilot project, the investigators implement and evaluate a computerized method for assessing treatment preferences of individuals with schizophrenia. The investigators use weight management treatments for this initial test of the system. If this assessment method is found to predict treatment use and satisfaction, it can be used to guide implementation of treatments that improve outcomes while meeting individuals' preferences.

Primary Outcome

Utilization of the weight services offered. This includes the number of days until starting to use weight services. This is assessed using information regarding attendance at weight services, and by survey administered by interview.

Interventions

  • BEHAVIORAL Psychosocial Weight Intervention

Study Locations (1)

California

  • UCLA Center for Health Services and Society - Los Angeles

Trial Details

FieldValue
Enrollment Target 61 participants
Start Date 2014-06-16
Est. Completion 2017-10-31
Phase NA

What the finished NCT02183844 record still lists

NCT02183844 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 61 participants, a relatively small participant target, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (93% lower).

The record links to 4 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which Psychosocial Weight Intervention is the first listed.

NCT02183844 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT02183844 about?

NCT02183844 is a clinical study titled "A System for Preference Assessment in Mental Health". It is important that individuals with serious mental illness make informed choices among alternative healthcare treatments based on their preferences. However, at present, individuals' preferences are often not being elicited, nor used to guide which treatments are made available. In this pilot proj...

What is the current status of trial NCT02183844?

This trial is currently completed. It is a NA study. The enrollment target is 61 participants. The study started on 2014-06-16. Estimated completion is 2017-10-31.

What conditions does trial NCT02183844 study?

This clinical trial studies the following conditions: Obesity, Schizophrenia, Overweight, Mental Disorders.

What interventions are being tested in trial NCT02183844?

The interventions under investigation include: Psychosocial Weight Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT02183844?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02183844 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02183844's enrollment target sits among peer trials

61 637th of 1053 higher than 413 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04115306 · 61 participants · Phase 1

    Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer

  • NCT05070845 · 61 participants · Phase 2

    Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia

  • NCT05187832 · 61 participants · Phase 1

    A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer

  • NCT05269316 · 61 participants · Phase 1

    Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02183844, the US trial registry maintained by the National Library of Medicine. NCT02183844 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.